The present invention is related to a shear-mode liquid-phase sensor. In particular, the present invention is related to a shear-mode liquid-phase sensor with a groove structure.
A biochip is a chip designed to detect or quantify target analytes such as protein, DNA, cell, glucose, cardiovascular disease biomarker, cancer biomarker, bacteria and virus. Many biochips are affinity-based, which means that they use a fixed capture probe on a sensing surface to bind the target analyte, and characteristic changes caused by the interaction between the fixed capture probe and the target analyte on the sensing surface are detected by a reader.
There are various important requirements for a sensor system, such as portability, low cost per test, maximum achievable sensitivity and specificity, and ease of use. Acoustic devices have found wide applications in chemical and biosensing fields owing to their high sensitivity, ruggedness and miniaturized design. Anything that influences the wave propagation or causes surface perturbations at device interface, would lead to a change in the characteristic parameters including resonance frequency, acoustic wave velocity and other acoustoelectric properties of these devices. Shear-mode liquid-phase sensors are shear-mode acoustic wave sensors that detect analytes in the liquid phase. Representative Shear-mode liquid-phase sensors include Shear Horizontal Surface Acoustic Wave (SH-SAW) sensors, Quartz Crystal Microbalance (QCM) sensors and Bulk Acoustic Wave (BAW) sensors.
Acoustic devices can use an antigen-antibody reaction to estimate the concentration of antigens in a biological sample through changes in the propagation characteristics of the acoustic waves.
There are usually different target analytes in the biological sample. For example, there are different proteins or biomarkers in the blood. In some cases, the acoustic devices cannot accurately analyze the amount or presence of the analyte, resulting in the decreased detection sensitivity. For example, some proteins of the same type have a common molecular, and this makes it impossible for the acoustic devices to distinguish the amount of a particular molecule from other molecules in the biological fluid. Alternatively, when the size of an analyte is relatively large (e.g., viral particles), the acoustic devices cannot detect the characteristic changes caused by the analyte in the liquid phase.
In order to overcome the above-mentioned problems existing in the sensor system, there is a need for a sensor system and a method that can analyze a target molecule in the biological sample with a better accuracy and sensitivity.
The present invention provides a shear-mode liquid-phase sensor having a groove structure for estimating the amount of target molecules in a biological liquid, wherein the amounts of the target molecules can be estimated by the shear-mode liquid-phase sensor with a better accuracy and sensitivity.
In one aspect, the present invention discloses a shear-mode liquid-phase sensor having a groove structure including a sensing area, over which a plurality of surface acoustic waves propagate, forming thereon the groove structure along a propagation direction of the plurality of surface acoustic waves, wherein the groove structure has a bottom surface to be bound with target molecules, a width ranging from 100% to 500% of a maximum length of each target molecule and a depth ranging from 50% to 500% of the maximum length of each target molecule.
The present invention further discloses a shear-mode liquid-phase sensor having a groove structure including a sensing area, over which a plurality of surface acoustic waves propagate, forming thereon the groove structure along a propagation direction of the plurality of surface acoustic waves, wherein the groove structure has a bottom surface to be bound with target molecules, a width ranging from 100% to 500% of a maximum length of each target molecule and a depth ranging from 50% to 500% of the maximum length of each target molecule, and wherein the groove structure comprises a plurality of sub-channels uniformly arranged along the propagation direction of the plurality of surface acoustic waves, and each sub-channel comprises a recess region and a flat region.
In another aspect, the present invention discloses a method of manufacturing a shear-mode liquid-phase sensor having a groove structure, the method includes the steps of:
The present invention further discloses a method using the shear-mode liquid-phase sensor having the groove structure in estimating an amount of specific molecules in a biological liquid, wherein the biological liquid includes a plurality of molecules having a common binding region, the method includes the steps of providing the shear-mode liquid-phase sensor having the groove structure, wherein the groove structure has the width corresponding to 100% to 500% of a maximum length of each specific molecule and the depth corresponding to 50% to 500% of the maximum length of each specific molecule, and the groove structure is coated with a probe binding to the common binding region, causing the plurality of molecules in the biological liquid to interact with the shear-mode liquid-phase sensor to trap the specific molecules in the groove structure, and estimating the amount of the specific molecules by measuring a characteristic change of the shear-mode liquid-phase sensor after the specific molecules are trapped in the groove structure.
The present invention further discloses a method using the shear-mode liquid-phase sensor having the groove structure in estimating an amount of target molecules in a biological liquid, wherein the shear-mode liquid-phase sensor comprises a sensing area including the groove structure, the method includes the steps of providing the shear-mode liquid-phase sensor having the groove structure, wherein the groove structure has the width corresponding to 100% to 500% of a maximum length of the target molecule and the depth corresponding to 50% to 500% of the maximum length of the target molecule, and the groove structure is coated with a probe binding to the target molecule, causing the target molecules in the biological liquid to interact with the shear-mode liquid-phase sensor and to be trapped in the groove structure, and estimating the amount of the target molecules by measuring a characteristic change of the shear-mode liquid-phase sensor after the target molecules are trapped in the groove structure.
The objectives and advantages of the present invention will become more readily apparent to those ordinarily skilled in the art after reviewing the following detailed descriptions and accompanying drawings.
The present invention will now be described more specifically with reference to the following embodiments. It is to be noted that the following descriptions of the preferred embodiments of this invention are presented herein for purpose of illustration and description only; they are not intended to be exhaustive or to be limited to the precise form disclosed.
The shear-mode liquid-phase sensor of the present invention is used to estimate an amount of specific molecules in a biological liquid. The shear-mode liquid-phase sensor in the present invention includes but is not limited to Shear Horizontal Surface Acoustic Wave (SH-SAW) sensor, Quartz Crystal Microbalance (QCM) sensor and a Bulk Acoustic Wave (BAW) sensor. The term “biological liquid” as used herein refers to the biological liquid such as urine, serum, whole blood, cell lysate, saliva, etc.
The term “molecule”, “target molecule” or “specific molecule” as used herein refers to a protein or a biomarker presenting in the above biological liquid that can interact with a probe fixed on the sensor, and includes but is not limited to lipoprotein, cholesterol, acute phase reactant (such as C-reactive protein (CRP) and serum amyloid A (SAA)), antibody and cytokine, or other substances presenting in the biological liquid. Additionally, the target molecule in the present invention may also include pathogens in the biological liquid, such as viral particle. The term “amount of the molecule” as used herein preferably refers to the concentration of the above-mentioned molecule in the biological liquid.
The sensing area 40 in
The width W and the depth D of the groove structure 401 can be varied to capture different target molecules. If the target molecule is a protein, the width W ranges from 10˜500 nm, such as 10˜400 nm, 10˜300 nm, 10˜200 nm, 10˜100 nm, 10˜80 nm, 10˜60 nm, 20˜60 nm and 40˜60 nm, and the depth D ranges from 5˜500 nm, such as 5˜400 nm, 5˜300 nm, 5˜200 nm, 10˜200 nm, 10˜150 nm, 10˜100 nm, 20˜100 nm, 30˜100 nm, 30˜80 nm and 30˜60 nm. If the target molecule is an antibody, the probe is an immunogenic protein, and the ranges of the width W and the depth D are similar to those for a protein. If the target molecule is a virus particle, the width W ranges from 100˜5,000 nm, such as 100˜4,000 nm, 100˜3,000 nm, 100˜2,000 nm, 100˜1,000 nm, 200˜1,000 nm and 200˜500 nm, and the depth D ranges from 50˜5,000 nm, such as 50˜4,000 nm, 50˜3,000 nm, 100˜3,000 nm, 100˜2,000 nm, 100˜1,000 nm, 200˜1,000 nm and 200˜500 nm.
Please refer to
The shear-mode liquid-phase sensor in the present invention can be configured with or without a reference channel. In the reference channel, the groove structure is not coated with the probe that binds to the target molecule. In the presence of the reference channel, some kinds of measurement errors can be compensated. However, the shear-mode liquid-phase sensor in the present invention can work without the reference channel.
In another aspect, the present invention provides a method of manufacturing a shear-mode liquid-phase sensor having a groove structure. The steps of the manufacturing method in the present invention will be described as follows.
In the manufacturing method of the present invention, a first material and a second material are used to form the electrodes and the sensing area, respectively. The first material and the second material may be the same material or different materials. When the first material and the second material are the same, the first material and the second material are deposited and patterned on the piezoelectric substrate 610 at the same time to form a base layer 620, as shown in
In
In the present invention, each groove of the groove structure has a bottom surface to be bound with target molecules, a width ranging from 100% to 500% of a maximum length of each target molecule and a depth ranging from 50% to 500% of the maximum length of each target molecule. Preferably, the width W ranges from 10˜5,000 nm or any range therebetween, and the depth D ranges from 5˜5,000 nm or any range therebetween.
In the shear-mode liquid-phase sensor in the present invention, the sensing area consists of one or more layers. In the first embodiment as shown in
The steps in
In the present invention, the first material is gold, aluminum, carbon or titanium, and the second material and the third material are independently selected from gold, tungsten, aluminum, carbon, titanium, silica (SiO2), zinc oxide (ZnO) and a combination thereof. Preferably, the second material is gold, and the third material is gold and/or SiO2.
The steps in
After the groove structure is formed on the sensing area, the method of manufacturing the shear-mode liquid-phase sensor of the present invention further includes a step of coating the probe on the bottom surface of the groove structure (not shown). The selection of the probe depends on the target molecule to be bound in the groove structure. If the target molecule is a protein (including an antigen), the probe is an antibody, a DNA molecule or an RNA molecule specific to the protein. If the target molecule is an antibody, the probe is an immunogenic protein such as spike protein and nucleocapsid protein of a virus. The probes used in the shear-mode liquid-phase sensor of the present invention include but are not limited to anti-ApoB100 antibody, anti-ApoA1 antibody, anti-ApoE antibody, anti-LP(a) antibody, anti-ApoB48 antibody, anti-C-reactive protein (CRP) antibody, anti-serum amyloid A (SAA) antibody, Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) immunogenic proteins, DNA molecule and RNA molecule.
In a further aspect, the present invention provides a method for estimating an amount of specific molecules in a biological liquid by using the shear-mode liquid-phase sensor having the groove structure. This method can estimate the amount of the specific molecules in the biological liquid containing different molecules having a common binding region.
In some specific case, some proteins have a common antigen, and the antibody for this common antigen can capture these proteins simultaneously. In other cases, some antibodies (IgA, IgM and IgG) have a common binding site for an immunogenic protein, and the immunogenic protein can bind to these antibodies simultaneously. As shown in Table 1, ApoB100 presents on chylomicron remnants (CH), very low-density lipoproteins (VLDL), intermediate density lipoproteins (IDL), lipoprotein (a) (LP(a)) and LDL, and thus anti-ApoB100 antibody can capture these lipoproteins simultaneously.
To distinguish one specific type of molecules among these molecules having the common binding region in the biological liquid, the shear-mode liquid-phase sensor having the groove structure in the present invention is provided to trap the specific molecules in the groove structure and allow the amount of the specific molecules to be estimated. Preferably, the common binding region is a common antigen or a binding site of an antibody. In order to capture the different molecules having the common binding region in the biological liquid, the probe binding to the common binding region is coated on the bottom surface of the groove structure. The groove structure has the width W and the depth D corresponding to the size of the specific molecule. For example, the width W corresponds to 100% to 500% of the maximum length of each specific molecule and the depth D corresponds to 50% to 500% of the maximum length of each specific molecule. In one embodiment, the specific molecule is a protein, and the width W preferably ranges from 10˜500 nm and the depth D preferably ranges from 5˜500 nm.
Then, the biological liquid is applied on the shear-mode liquid-phase sensor to cause the molecules in the biological liquid to interact with the shear-mode liquid-phase sensor and to cause the specific molecules to bind with the probes on the groove structure. Because the different molecules in the biological liquid have different sizes, only the specific molecules can be trapped in the groove structure that fits the size of the specific molecule. Optionally, a washing process is performed to take off undesired molecules that do not bind to the probe in the groove structure after the specific molecules are trapped in the groove structure.
After the specific molecules are trapped in the groove structure, the amount of the specific molecules can be estimated by measuring characteristic change (e.g., phase change and amplitude change) of the shear-mode liquid-phase sensor.
In a further aspect, the present invention provides a method for estimating an amount of target molecules in a biological liquid by using the shear-mode liquid-phase sensor having the groove structure. This method can estimate the amount of the target molecules with a large size in the biological liquid by the shear-mode liquid-phase sensor.
Conventionally, it is difficult to estimate the amount of molecules with a large size (e.g., a pathogen such as virus) in the biological liquid by using the conventional shear-mode liquid-phase sensor in the art.
To estimate the amount of the molecules with a large size in the biological liquid, the shear-mode liquid-phase sensor having the groove structure in the present invention is provided to trap the target molecules in the groove structure and enable the amount of the target molecules to be estimated. In order to capture the target molecules in the biological liquid, the probe binding to the target molecules is coated on the bottom surface of the groove structure. The groove structure has the width W and the depth D corresponding to the size of the target molecule. For example, the width W corresponds to 100% to 500% of the maximum length of each target molecule and the depth D corresponds to 50% to 500% of the maximum length of each target molecule. In one embodiment, the target molecule is a virus, and the width W preferably ranges from 100˜5,000 nm and the depth D preferably ranges from 50˜5,000 nm.
Then, the biological liquid is applied on the shear-mode liquid-phase sensor to cause the target molecules in the biological liquid to interact with the shear-mode liquid-phase sensor and to be trapped in the groove structure. Optionally, a washing process is performed to take off undesired molecules that do not bind to the probe in the groove structure after the target molecules are trapped in the groove structure. After the target molecules are trapped in the groove structure, the amount of the target molecules can be estimated by measuring characteristic change (e.g., phase change and amplitude change) of the shear-mode liquid-phase sensor.
By using the shear-mode liquid-phase sensor and the methods in the present invention, the analyses for the amount or presence of some particular molecules in a sample can be achieved accurately. In addition, the present invention provides a sensitive approach to analyze the target molecules in the biological sample by the shear-mode liquid-phase sensor.
These and other modifications and variations to the invention may be practiced by those of ordinary skill in the art without departing from the spirit and scope of the invention, which is more particularly set forth in the appended claims. In addition, it should be understood that aspects of the various embodiments may be interchanged in whole or in part. Furthermore, those of ordinary skill in the art will appreciate that the foregoing description is by way of example only, and it is not intended to limit the invention as further described in such appended claims. Therefore, the spirit and scope of the appended claims should not be limited to the exemplary description of the versions contained herein.